Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Type 2 diabetes mellitus
Age: Adult
Condition: Conventional preparation
Dose: Oral preparation – 500 mg
Frequency: twice daily or three times daily
Note: Initially 500 mg twice daily or three times daily, or 850 mg 1-2 times daily, may increase gradually to 2000 mg daily at intervals of at least 1 week. Maximum daily dose of 2550 mg per day.
Indication: Type 2 diabetes mellitus
Age: Adult
Condition: Modified-release preparation
Dose: Oral preparation – 500 mg
Frequency: once daily
Note: Initially 500 mg once daily, may increase in increments of 500 mg at intervals of at least 1 week to maximum 2000 mg once daily at night. If glycaemic control is not sufficient, dose may be divided to 1000 mg twice daily. Not to exceed 2000 mg/day.

Child Dose

Clinical InformationAdministration Information
Indication: Type 2 diabetes mellitus
Age: greater than 10 yr
Dose: Oral – 500 mg
Frequency: 1-2 times daily
Note: initially, may increase gradually to maximum 2000 mg daily in 2 or 3 divided doses at intervals of at least 1 week
Indication: Type 2 diabetes mellitus
Age: greater than 10 yr
Dose: Oral – 850 mg
Frequency: once daily
Note: initially, may increase gradually to maximum 2000 mg daily in 2 or 3 divided doses at intervals of at least 1 week

Renal Dose

Clinical InformationAdministration Information
Age: Elderly
Condition: Renal impairment
Dose: Tablet – Dosage not specified
Note: Monitor estimated glomerular filtration rate at least annually or more often for those at risk for renal impairment
Condition: Renal impairment with estimated glomerular filtration rate less than 30 mL/min/1.73 m2
Dose: Tablet – Dosage not specified
Note: Contraindicated; discontinue the drug if estimated glomerular filtration rate falls below 30 mL/min/1.73 m2 while taking metformin
Administration
  • Take with food
  • Take with meals to reduce stomach upset
Side Effect

Drug Interaction

Drug NameRisk Factors
Sulfonylureas
Additive effect
Thiazide diuretics (Chlorothiazide, Chlorthalidone, Hydrochlorothiazide, Indapamide, Metolazone), Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone), Phenothiazines, Oral contraceptives, Sympathomimetics (Ephedrine, Pseudoephedrine, Phenylephrine), Niacin, Calcium Channel Blockers (Amlodipine, Diltiazem, Verapamil, Nifedipine, Felodipine, Nicardipine, Isradipine), Isoniazid
May exacerbate loss of glycaemic control

Disease Interaction

Disease NameRisk Factors
Acute/Chronic Metabolic Acidosis
Can worsen acid-base balance
Diabetic Ketoacidosis
Increases risk of severe acidosis

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.